Similar to the Ela-KRAS transgenics [107], the Pdx1-Cre KrasLSL−G12D double mutants (often referred to as the “KC model”) provided evidence for a pivotal role of mutant KRAS in the formation of PanIN lesions that have the propensity to progress into invasive PDAC. This evidence concerns the gene KRAS and keratoconus.